Drug Type Small molecule drug |
Synonyms dodecafluoropentane, EchoGen, Perflenapent/Perflisopent + [4] |
Target |
Mechanism Potassium channel modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseWithdrawn |
First Approval Date EU (17 Jul 1998), |
Regulation- |
Molecular FormulaC5F12 |
InChIKeyNJCBUSHGCBERSK-UHFFFAOYSA-N |
CAS Registry678-26-2 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Cardiovascular Diseases | EU | 17 Jul 1998 | |
Cardiovascular Diseases | IS | 17 Jul 1998 | |
Cardiovascular Diseases | LI | 17 Jul 1998 | |
Cardiovascular Diseases | NO | 17 Jul 1998 |
Phase 1/2 | 24 | tfamunudcq(hvgniodscl) = Early initiation of DDFPe treatment resulted in better NIHSS score response than late initiation (P = 0.03). oxyhtbkykk (bhhkiwykso ) View more | Positive | 01 Aug 2019 | |||
Placebo | |||||||
Not Applicable | - | 6 | gxydykszvx(mnprslsmng) = rqzjlsmofp ocyjfwtgez (tmoxddvltz ) View more | - | 01 Feb 2015 | ||
Not Applicable | - | 8 | (Single bolus (0.6 mL/kg)) | onmomxgvld(csajpceymd) = bdbsxryetl jlvtpqeehz (oiklaqwzxc ) View more | - | 01 Feb 2013 |